Home

CVS Health Corporation - Financial Overview

Ticker - CVS

Close PriceMarket CapP/E RatioForward P/E RatioImplied Growth*Implied Forward Growth*P/B Ratio
$67.29$84.95B18.410.410.6%4.7%1.1

Revenue and Net Income Chart EPS Chart
  Date Revenue Net Income EPS Revenue Change Net Income Change EPS Change
0 2020-12-31 $268.7B $7.2B $5.48 N/A N/A N/A
1 2021-12-31 $292.1B $8.0B $6.00 8.7% 11.5% 9.5%
2 2022-12-31 $322.5B $4.3B $3.29 10.4% -46.1% -45.2%
3 2023-12-31 $357.8B $8.3B $6.49 10.9% 93.6% 97.3%
4 2024-12-31 $372.8B $4.6B $3.67 4.2% -44.7% -43.5%
5 TTM 2024-12-31 $372.8B $4.6B $3.66 0.0% 0.0% -0.3%
6 Average 6.8% 2.9% 3.6%




CVS - Forecast Data



CVS - Y/Y % Change

  Metric Value
0 Total Assets $253,215M
1 Cash $8,586M
2 Total Liabilities $177,485M
3 Total Debt $82,920M
4 Total Equity $75,560M
5 Debt to Equity Ratio 1.10
CVS Balance Sheet Chart



CVS - Valuation Chart


Valuation Chart

Share Price Treasury Yield Estimates Fair Value (P/E) Fair Value (P/S) Current P/S Current P/E
$67.29 4.3% Nicks Growth: 5%
Nick's Expected Margin: 2%
FINVIZ Growth: 14%
Nicks: 11
Finviz: 24
Nick's: 0.215 0.2 18.4
Basis Year Nicks Valuation Nicks vs Share Price Finviz Valuation Finviz vs Share Price
$3.66 EPS TTM $39.32 -41.6% $88.65 31.7%
$5.89 EPS 2025 $63.28 -6.0% $142.67 112.0%
$6.81 EPS 2026 $73.17 8.7% $164.95 145.1%